ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $151,000 | -23.4% | 355,172 | +16.2% | 0.00% | – |
| Q4 2016 | $197,000 | -77.6% | 305,781 | +9.5% | 0.00% | – |
| Q3 2016 | $879,000 | +16.1% | 279,265 | +13.9% | 0.00% | – |
| Q2 2016 | $757,000 | -13.6% | 245,258 | +1.3% | 0.00% | – |
| Q1 2016 | $876,000 | -21.2% | 242,004 | +1.0% | 0.00% | -100.0% |
| Q4 2015 | $1,112,000 | -28.8% | 239,709 | -6.5% | 0.00% | 0.0% |
| Q3 2015 | $1,561,000 | -20.4% | 256,398 | +12.8% | 0.00% | 0.0% |
| Q2 2015 | $1,960,000 | +192.5% | 227,380 | +51.5% | 0.00% | – |
| Q1 2015 | $670,000 | +355.8% | 150,068 | +61.1% | 0.00% | – |
| Q4 2014 | $147,000 | -17.4% | 93,172 | 0.0% | 0.00% | – |
| Q3 2014 | $178,000 | -43.5% | 93,172 | 0.0% | 0.00% | – |
| Q2 2014 | $315,000 | +1.0% | 93,172 | 0.0% | 0.00% | – |
| Q1 2014 | $312,000 | +9.1% | 93,172 | 0.0% | 0.00% | – |
| Q4 2013 | $286,000 | -23.7% | 93,172 | -0.2% | 0.00% | – |
| Q3 2013 | $375,000 | – | 93,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 861,723 | $1,174,000 | 0.98% |
| R&F Capital Advisors LP | 171,205 | $111,000 | 0.04% |
| Rhenman & Partners Asset Management AB | 200,000 | $130,000 | 0.02% |
| Rock Springs Capital Management LP | 380,000 | $247,000 | 0.02% |
| WHITE PINE CAPITAL LLC | 35,000 | $23,000 | 0.01% |
| BVF INC/IL | 62,292 | $40,000 | 0.01% |
| Virtu KCG Holdings LLC | 271,239 | $176,000 | 0.00% |
| TURNER INVESTMENTS LLC | 15,000 | $10,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11,736 | $8,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 36,413 | $24,000 | 0.00% |